Klinic Review
Best for: brand-name Wegovy & Zepbound through insurance (Medicare/Medicaid OK) or self-pay, all 50 states
Klinic is a LegitScript-certified multi-condition telehealth platform prescribing brand-name GLP-1 medications—Wegovy (semaglutide) and Zepbound (tirzepatide)—to patients across all 50 U.S. states. The service accepts most major insurance plans including Medicare and Medicaid; self-pay visit fees start at $99. Klinic's pharmacy hub coordinates prior authorization and home delivery, and the platform also covers addiction (MAT) and mental health alongside weight management.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Billed separately
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Klinic is a solid telehealth option with balanced features and pricing.
Klinic at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Brand Wegovy (semaglutide), Brand Zepbound (tirzepatide)
- Starting price
- $299/mo (Verbatim from /wegovy: 'approximately $499 per month through Novocare pharmacy, but it can start as low as $149.' Self-pay medication cost; consult fees ($99 initial visit, $75 follow-up) are additional. coverage: 'as low as $0 + Copay.' Accepts United Healthcare, BCBS, Aetna, Cigna, Humana, Medicare Part D, Medicaid.)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Klinic
Each dimension is scored algorithmically from Klinic’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.1/10At $299/mo, Klinic runs about 76% above the $170 median for GLP-1 providers.
Effectiveness25%
9.0/10Klinic offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
8.0/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.9/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-04).
Accessibility10%
7.0/10Klinic's exact state footprint isn't published — confirm coverage in your state before signing up. Insurance pathways are offered for eligible patients.
Support10%
6.1/10Coaching not included in the base price.
How we verified this Klinic review
Last checked 2026-07-04- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Klinic offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Verbatim from /wegovy: 'approximately $499 per month through Novocare pharmacy, but it can start as low as $149.' Self-pay medication cost; consult fees ($99 initial visit, $75 follow-up) are additional. coverage: 'as low as $0 + Copay.' Accepts United Healthcare, BCBS, Aetna, Cigna, Humana, Medicare Part D, Medicaid.
Verbatim from /tirzepatide: 'Zepbound starts as of $299 a month.' Self-pay medication cost; consult fees ($99 initial, $75 follow-up) are additional. coverage: 'With coverage you pay as low as $0 + Copay.' Prior authorization handled by Klinic.
Ready to get started?
Plans and promotions change often — check Klinic's current pricing and active discounts before you decide.
What we like
- LegitScript certified, licensed in all 50 states, DEA registered, HIPAA/SOC 2 Type II compliant
- Broad insurance acceptance including Medicare, Medicaid, BCBS, Aetna, Cigna, UHC, and Humana
- Klinic handles all prior authorization—patient never manages PA paperwork
- Brand-name FDA-approved GLP-1s (Wegovy, Zepbound) at full clinical doses with home delivery
- Named clinical leadership (CMO Dr. Saba Haq, Chief Physician Dr. Vivek Chander) and disclosed founder
Watch-outs
- Brand-name meds are costly self-pay: Wegovy ~$499/month, Zepbound ~$299/month (med cost alone; consult extra)
- No compounded semaglutide or tirzepatide option for patients seeking lower-cost alternatives
- Medication cost is separate from visit fees ($99 initial, $75 follow-up) — total self-pay cost is higher
- No labs or dedicated nutrition/coaching program included in any plan
- Pharmacy fulfillment via Klinic Pharmacy Hub Services LLC (non-dispensing hub); actual dispensing is third-party
Is Klinic worth it? Our verdict
Klinic positions itself around one thing: brand-name Wegovy & Zepbound through insurance (Medicare/Medicaid OK) or self-pay, all 50 states. It runs $299/month — a premium to the category, so the extras need to justify it.
Beyond the core GLP-1 program, Klinic leans on Brand Wegovy (semaglutide), Brand Zepbound (tirzepatide), and Insurance accepted.
How much Klinic actually costs
- Brand-name semaglutide — $499/month
- Brand-name tirzepatide — $299/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so Klinic's standing rate sits at the premium end.
For a direct comparison, Direct Meds runs semaglutide and tirzepatide from $249/month — worth pricing against Klinic before you commit.
Medications: what Klinic prescribes
Klinic prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as FDA-approved brand-name products rather than compounded formulations.
Who Klinic is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. We explain how we weigh medical oversight and compliance in our scoring methodology.
Bottom line
Klinic costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Embody is one of the closest alternatives we track — worth a look before deciding.
Ready to start with Klinic?
Starting at $299/month. See current pricing and start your free consultation.
Alternatives to Klinic
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Klinic review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Klinic?
Starting at $299/month. See current pricing and start your free consultation.